Sign In
Buy NVTA
$0.0190
+0 (+0%)
At Close: May 13, 2024
Earnings Preview: Invitae
10:07am, Tuesday, 16'th Feb 2021
Invitae (NYSE:NVTA) unveils its next round of earnings this Wednesday, February 17. Here is Benzinga's everything-that-matters guide for the earnings announcement.
3 Healthcare Stocks I'd Buy Right Now
06:22am, Monday, 15'th Feb 2021
Two innovative small companies with scorching growth and one bargain biotech.
Invitae (NVTA) Stock Sinks As Market Gains: What You Should Know
06:56pm, Friday, 05'th Feb 2021
In the latest trading session, Invitae (NVTA) closed at $49.70, marking a -0.98% move from the previous day.
Healthcare Expert: These Are the Most Important Lessons From the Pandemic
07:15am, Monday, 01'st Feb 2021
The takeaways go beyond coronavirus testing, treatments, and vaccines.
The InvestorPlace Q&A: Genomics, Telehealth and the Future of Healthcare with the ANEW ETF
08:21am, Wednesday, 27'th Jan 2021
One aspect of the ANEW ETF is focused on the bleeding edge of medical advances. Here's what you need to know if you're considering investing.
SAN FRANCISCO, Jan. 26, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA) today announced the closing of its underwritten public offering of 8,932,038 shares of its common stock, including 1,165,0
Invitae Announces Pricing of Public Offering of Common Stock
08:37pm, Thursday, 21'st Jan 2021
SAN FRANCISCO, Jan. 21, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA) today announced the pricing of an underwritten public offering of 7,766,990 shares of its common stock at a price to the p
Invitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia Project
02:08pm, Thursday, 14'th Jan 2021
Those are some solid endorsements.
Why Invitae Stock Flew Higher Today
04:17pm, Wednesday, 13'th Jan 2021
Investors appear to like the company's new collaboration with PacBio.
7 Hot Stocks to Buy Now Before They Take Off
09:18am, Wednesday, 06'th Jan 2021
Supporting the case for being constructive on stocks in 2021is the sheer depth of where hot stocks hail from. Last year, the technology and consumer discretionary sectors were the two largest contribu
Fulgent: COVID-19 Is Not Over Yet
12:30pm, Tuesday, 05'th Jan 2021
Fulgent: COVID-19 Is Not Over Yet
Move Over, Warren Buffett: This Is the Star Investor You Should Be Following
11:55pm, Wednesday, 30'th Dec 2020
Berkshire's best days seem to be behind it, but this investing wiz could be the next Buffett.
Invitae to Present at the 39th Annual J.P. Morgan Healthcare Conference
07:30am, Tuesday, 29'th Dec 2020
SAN FRANCISCO, Dec. 29, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George, co-founder and chief executive officer of Invitae,
4 Companies At The Center Of The Telemedicine And Digital Health Revolution
02:37pm, Monday, 21'st Dec 2020
The rapid adoption of telemedicine and digital health during COVID-19 pandemic is remarkable, yet unsurprising. In the years preceding the health crisis we now find ourselves in, a paradigm shift in h
Invitae: Network Strategy And Industry Tailwinds Should Offer Path To Profitability
01:03am, Monday, 21'st Dec 2020
The cost of sequencing a human genome has been falling faster than Moore's law. The interpretation of results is another important aspect to consider to reduce costs.
